CYNTHIA GAVILANES: Open Payments
NPI 1629178983 · PEMBROKE PINES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,553 in 74 payments from 17 companies in 2025. Trend: 2023 $1,944 · 2024 $1,372 · 2025 $1,553
Food & beverage: $1,485Education: $68
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 25 | $481 |
| Bayer Healthcare Pharmaceuticals Inc. | 13 | $271 |
| Myriad Genetic Laboratories, Inc. | 4 | $124 |
| Sumitomo Pharma America, Inc. | 5 | $92 |
| Verity Pharmaceuticals Inc. | 4 | $81 |
| PFIZER INC. | 3 | $76 |
| Ferring Pharmaceuticals Inc. | 3 | $68 |
| Merck Sharp & Dohme LLC | 2 | $58 |
| Boston Scientific Corporation | 4 | $54 |
| Astellas Pharma US Inc | 2 | $51 |
Products named: ERLEADA, Nubeqa, Xtandi, PROLARIS, RYBREVANT, GEMTESA, ADSTILADRIN, KEYTRUDA.
Industry payments across FL — which companies pay providers there.
